Summary of Significant Accounting Policies - Schedule of Anti-Dilutive Securities (Details) - shares	9 Months Ended
Sep. 30, 2023	Sep. 30, 2022
Net loss per share
Anti-dilutive securities (in shares)	6,515,345	16,569,784
Convertible preferred stock and exchangeable shares
Net loss per share
Anti-dilutive securities (in shares)	0	9,936,148
Stock options
Net loss per share
Anti-dilutive securities (in shares)	6,515,345	3,426,929
Conversion of convertible promissory note
Net loss per share
Anti-dilutive securities (in shares)	0	3,206,707

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration